Ad-IFN-alpha (MD Anderson Cancer Center/NCI)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAd-IFN-alpha (MD Anderson Cancer Center/NCI)
Drug Alias Nameadenoviral-mediated IFN-alpha (MD Anderson Cancer Center/NCI)oncolytic adenovirus therapy expressing IFNa (MD Anderson Cancer Center/NCI)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterferon alpha ligand
TargetsInterferon alpha
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A